Compare IDEXX Laboratories, Inc. (IDXX) vs T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs T-Rex 2X Inverse MSTR Daily Target ETF — how do they compare? IDEXX Laboratories, Inc. trades at $563.81 (market cap $44.48B), while T-Rex 2X Inverse MSTR Daily Target ETF trades at $10.5. The key difference: T-Rex 2X Inverse MSTR Daily Target ETF is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| IDXX | MSTZ | |
|---|---|---|
Market Cap | $44.48B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $766.68 | $27.92 |
52-Week Low | $520.87 | $3.50 |
Enterprise Value | $45.38B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories trades at $552.46, down 2.64% today, with neutral technical signals but strong fundamental performance. The company maintains robust profitability with 24.63% net margins and has beaten earnings expectations for three consecutive quarters. Recent news highlights AI integration in medical devices and upcoming Q2 2026 results on August 4, 2026. The stock shows consistent revenue growth from $3.4B in 2022 to $4.3B in 2025.
Outlook remains positive given earnings momentum and analyst consensus, though elevated valuation ratios (P/E 41.49) pose risks. Key catalysts include Q2 earnings release and continued AI adoption in veterinary diagnostics. Primary risks involve competitive pressures and market volatility affecting premium valuations.
MSTZ is trading at $11.49, down 6.2% today, with mixed technical signals showing bearish moving averages but neutral oscillators. The stock faces resistance at $12 and support at $11. Financial ratios remain unavailable, limiting fundamental assessment. Recent news highlights ETF performance trends but provides limited direct company insights.
The outlook remains uncertain due to incomplete financial data and mixed technical indicators. Investment opportunity depends on forthcoming financial disclosures, while risks include market volatility and lack of clear fundamental anchors. Current sentiment appears neutral with limited analyst coverage.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About T-Rex 2X Inverse MSTR Daily Target ETF
MSTZ is a leveraged ETF that seeks daily investment results corresponding to 200% of the inverse (opposite) of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bearish position on MSTR, a company known for its large Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from its stated daily objective.
Read more on MSTZ →
